Abstract:Ethylene oxide (EtO) is a highly reactive organic compound that is mainly used as a sterilizing agent. However, to date, the effects of EtO on the cardiovascular system are not clear. We aimed to explore the association between blood EtO levels and the risk of cardiovascular disease (CVD) in the general US population. We obtained information on blood levels of EtO and CVD outcomes in 3,410 participants from the National Health and Nutritional Examination Survey (NHANES) 2013–2014 and 2015–2016. Logistic regression models were applied to calculate the odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between EtO and risk of all CVD as well as subtypes of CVD. Linear regression analyses were used to estimate the associations of EtO with potential mechanistic parameters of CVD, including blood pressure, blood lipid levels and inflammatory parameters. Higher blood levels of EtO were associated with an increased risk of all CVD (p for trend = 0.003), with an adjusted OR (95% CI) in the highest quartile of 1.94 (1.24, 3.02) compared with the lowest quartile as a reference. Higher concentrations of EtO were positively associated with the risk of angina (p for trend = 0.04) and heart attack (p for trend = 0.011). In addition, the concentration of EtO was positively associated with the levels of triglycerides, white blood cells, lymphocytes, monocytes, neutrophils and eosinophils (p = 0.003 for eosinophils and p < 0.001 for the others) and negatively associated with the level of high-density lipoprotein cholesterol (p < 0.001). We found that exposure to EtO was associated with angina, heart attack and all CVD in a large representative US population. Furthermore, EtO may induce CVD through the inflammatory response and abnormal fatty acid metabolism.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the association between ethylene oxide (EtO) levels in the blood and the risk of cardiovascular disease (CVD). Specifically, the study aims to: 1. **Determine the relationship between EtO exposure and overall CVD risk**: By analyzing the relationship between blood EtO levels and the incidence of CVD in the general US population, assess whether EtO increases the risk of CVD. 2. **Explore the relationship between EtO and CVD subtypes**: Including specific types of cardiovascular diseases such as angina pectoris and heart attacks, to understand the impact of EtO on different types of CVD. 3. **Explore potential mechanism parameters**: Such as blood pressure, blood lipid levels, and inflammation parameters, to reveal the mechanism by which EtO affects the cardiovascular system. ### Research Background - **Basic information about EtO**: Ethylene oxide (EtO) is a highly reactive organic compound, mainly used for the sterilization of medical devices and as an intermediate in the production of other chemical substances. - **Deficiencies in existing research**: Although previous studies have shown that EtO may be carcinogenic, there are few studies on the impact of EtO on the cardiovascular system. - **Research significance**: Through this study, scientific basis can be provided for public health protection measures and guide future research directions. ### Main Findings - **Overall CVD risk**: Higher blood EtO levels were significantly associated with an increased risk of all CVDs (p - trend = 0.003), and the adjusted OR (95% CI) in the highest quartile was 1.94 (1.24, 3.02). - **CVD subtypes**: Higher concentrations of EtO were significantly associated with an increased risk of angina pectoris (p - trend = 0.04) and heart attacks (p - trend = 0.011). - **Mechanism parameters**: EtO concentration was positively correlated with the levels of triglycerides, white blood cells, lymphocytes, monocytes, neutrophils, and eosinophils (p < 0.001), and negatively correlated with the level of high - density lipoprotein cholesterol (p < 0.001). ### Conclusions The study is the first to find the association between EtO exposure and the risk of angina pectoris, heart attacks, and all CVDs in a large - sample general US population. Specific populations (such as men, non - Hispanic whites, older people, obese people, those with a smoking history, and those lacking physical activity) are more likely to be affected by EtO - related CVD. In addition, EtO may induce CVD through inflammatory responses and abnormal fatty acid metabolism. ### Formula Presentation - **Adjusted Odds Ratio (OR)**: \[ \text{Adjusted OR}=\exp(\beta) \] where \(\beta\) is the regression coefficient, representing the log - odds ratio of EtO concentration to CVD risk. - **Confidence Interval (CI)**: \[ \text{95% CI}=\exp(\beta\pm1.96\times SE) \] where \(SE\) is the standard error. These formulas are used to calculate and interpret the relationship between EtO concentration and CVD risk and its statistical significance.

Association between blood ethylene oxide levels and the risk of cardiovascular diseases in the general population

Associations between Ethylene Oxide Exposure and Liver Function in the US Adult Population

Association between blood ethylene oxide levels and periodontitis risk: a population-based study

Association Between Ethylene Oxide Exposure and Cognitive Function in US Older Adults: NHANES 2013-2014

Association of the blood levels of specific volatile organic compounds with nonfatal cardio-cerebrovascular events in US adults

Ethylene oxide exposure, inflammatory indicators, and depressive symptoms: a cross-sectional study and mediation analysis based on a non-institutionalized American population

Exposure to BTEX is associated with cardiovascular disease, dyslipidemia and leukocytosis in national US population

Association between ethylene oxide exposure and periodontitis: a cross-sectional study from NHANES 2013–2014

Associations between ethylene oxide exposure and biological age acceleration: evidence from NHANES 2013–2016

Ethylene oxide review: characterization of total exposure via endogenous and exogenous pathways and their implications to risk assessment and risk management

Blood Levels of Organochlorine Contaminants Mixtures and Cardiovascular Disease

Associations between specific volatile organic chemical exposures and cardiovascular disease risks: insights from NHANES

Association between urinary metabolites of volatile organic compounds and cardiovascular disease in the general population from NHANES 2011–2018

Exposure to Acrylamide and the Risk of Cardiovascular Diseases in the National Health and Nutrition Examination Survey 2003–2006

Associations of urinary volatile organic compounds with cardiovascular disease among the general adult population

Exposure to volatile organic compounds and mortality in US adults: A population-based prospective cohort study

Association of Co-Exposure to Organophosphate Esters and Per- and Polyfluoroalkyl Substances and Mixture with Cardiovascular-Kidney-liver-metabolic Biomarkers among Chinese Adults

Association of Aldehyde Exposure with Cardiovascular Disease

Mediating Role of Glucose-Lipid Metabolism in the Association between the Increased Risk of Coronary Heart Disease and Exposure to Organophosphate Esters, Phthalates, and Polycyclic Aromatic Hydrocarbons

Assessing volatile organic compounds exposure and chronic obstructive pulmonary diseases in US adults

Using three statistical methods to analyze the association between aldehyde exposure and markers of inflammation and oxidative stress